Login / Signup

Development and Validation of [ 3 H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs.

Hazem AhmedLivio GislerNehal H ElghazawyClaudia KellerWolfgang SipplSteven H LiangAhmed HaiderSimon M Ametamey
Published in: Pharmaceuticals (Basel, Switzerland) (2022)
GluN2B-enriched N -methyl-D-aspartate receptors (NMDARs) are implicated in several neurodegenerative and psychiatric diseases, such as Alzheimer's disease. No clinically valid GluN1/2B therapeutic exists due to a lack of selective GluN2B imaging tools, and the state-of-the-art [ 3 H]ifenprodil shows poor selectivity in drug screening. To this end, we developed a tritium-labeled form of OF-NB1, a recently reported selective GluN1/2B positron emission tomography imaging (PET) agent, with a molar activity of 1.79 GBq/µmol. The performance of [ 3 H]OF-NB1 and [ 3 H]ifenprodil was compared through head-to-head competitive binding experiments, using the GluN1/2B ligand CP-101,606 and the sigma-1 receptor (σ1R) ligand SA-4503. Contrary to [ 3 H]ifenprodil, the usage of [ 3 H]OF-NB1 differentiated between GluN1/2B and σ1R binding components. These results were corroborated by observations from PET imaging experiments in Wistar rats using the σ1R radioligand [ 18 F]fluspidine. To unravel the binding modes of OF-NB1 and ifenprodil in GluN1/2B and σ1Rs, we performed a retrospective in silico study using a molecular operating environment. OF-NB1 maintained similar interactions to GluN1/2B as ifenprodil, but only ifenprodil successfully fitted in the σ1R pocket, thereby explaining the high GluN1/2B selectivity of OF-NB1 compared to ifenprodil. We successfully showed in a proof-of-concept study the superiority of [ 3 H]OF-NB1 over the gold standard [ 3 H]ifenprodil in the screening of potential GluN1/2B drug candidates.
Keyphrases
  • pet imaging
  • positron emission tomography
  • computed tomography
  • high resolution
  • emergency department
  • stem cells
  • bone marrow
  • dna binding
  • mild cognitive impairment
  • drug induced
  • molecular dynamics simulations